Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease.
Molecular genetics and metabolism·2013
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.
Clinical pharmacology and therapeutics·2009
Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Long-term outcome in methylmalonic aciduria: a series of 30 French patients.
Molecular genetics and metabolism·2009
[Natal and neonatal teeth. Management].
Annales de pediatrie·1993
[Risks of failure of uncontrolled adoption of foreign children].
Annales de pediatrie·1993
[Hepatic hydatidosis and portal hypertension in children. Is it the Budd-Chiari syndrome?].
Annales de pediatrie·1993
[Neonatal testicular ischemic necrosis without torsion, associated with antithrombin III deficit].
Annales de pediatrie·1993
[Diffuse neonatal hemangiomatosis. A case with tetralogy of Fallot].
Annales de pediatrie·1993
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026